In the Press

Atopic dermatitis (AD) is one of the most common chronic skin disorders globally.[1] A recent systematic review, with data from all continents, found a 12-month prevalence of AD up to 17·1% among adults and 22·6% among children.[2]

Persistent infection with certain types of human papillomavirus (HPV) in pregnant women may increase the risk of preterm birth, according to a study led by CHU Sainte-Justine researcher and Université de Montréal associate professor Helen Trottier.

Asthma affects approximately 10% of school-aged children in the United States, with higher prevalence and morbidity being demonstrated among low-income and minority populations (1–4).

Glioblastoma is the most lethal and malignant adult brain cancer that may arise from neuroglial stem or progenitor cells. Certain gene mutations or those with a known history of other cancers and radiation therapy may predispose patients to develop brain cancer. Tumor relapse is invariably inevitable due to the resistance of glioblastoma towards standard therapies. Additionally, the infiltrative nature of these tumor cells means it is often not possible to surgically remove them completely.

Researchers from the University of Sheffield have discovered a new gene therapy pathway that has uncovered an important regulatory mechanism to keep our genome healthy. This pathway has the potential to protect us against serious life-limiting diseases such as cancer and dementia

Bristol-led research has identified specific drug targets within the neural circuits that encode memories, paving the way for significant advances in the treatment of a broad spectrum of brain disorders.

AMs from COPD patients undergo GOLD grade-specific transcriptional reprogramming and acquire a complex activation profile. Among the observed changes are gene programmes involved in lipid metabolism that translate into alterations in the AM lipidome.

t was coronavirus disease (COVID-19) day 69 in the United States, 29 in New York State and 17 in New York Presbyterian Hospital. I (D.L.C.-L.) was halfway through an endoscopic retrograde on an intubated COVID-19-positive patient, wearing all of my mandated personal protective equipment (PPE), including the same N95 mask that I had worn throughout the day, with a covering surgical mask and welder's-type face shield. Having just performed a sphincterotomy for choledocholithiasis, I realized I could smell the characteristic aroma of burning tissue as I withdrew the sphincterotome from the duodenoscope channel.

This document lays out proposed ventilation and air cleaning requirements for governments, businesses, and building operators. SARS-CoV-2 transmission is higher indoors than outdoors¹ and transmission is substantially reduced by indoor ventilation.² The failure to enhance ventilation and air cleaning puts the users of buildings at unnecessary risk.

Scientists, typically, are on their own after their post-doc ends. Sometimes, albeit rarely, they team up, blending their ideas, money, and people. Connie Cepko, PhD, and Cliff Tabin, PhD, pioneered the idea of a lab partnership, spending the last few decades working together in their shared lab at Harvard Medical School.